What amount sold does Vernal Biosciences, Inc. report in Form D filings?

The latest linked filings report $42.5M sold across 2 identified offering(s). 0 unlinked amendment(s) are excluded; 0 offering(s) have no reported amount sold. This is not verified lifetime funding or money raised during a specific period.

When was Vernal Biosciences, Inc.'s most recent SEC filing?

Vernal Biosciences, Inc.'s most recent Form D filing was on 2023-06-16.

How many investors does Vernal Biosciences, Inc. have?

The most recent Form D filing lists 10 investor(s).

What type of securities does Vernal Biosciences, Inc. offer?

Vernal Biosciences, Inc.'s SEC Form D filings indicate equity offerings.

Vernal Biosciences, Inc.

CIK: 0001861147·Biotechnology·Colchester, VT·Corporation·Founded 2020

Reported Sold

$42,498,390

Total Filings

Identified Offerings

Last Filed

Jun 16, 2023

Employees

—

Reported sold uses the latest linked filing for each identified offering; it is not verified lifetime funding. SPV filings are shown separately.

About

Company in Biotechnology industry

SEC EDGAR

Offering filing timeline

Jun 16, 2023Form D/A — Amendment

Reported sold: $40,998,390 · Target: $40,998,390

Rule 506(b)·10 investors

Changed: Reported amount sold, Offering target

May 25, 2022Form D — New notice

Reported sold: $20,998,407 · Target: $20,998,407

Rule 506(b)·10 investors

May 24, 2021Form D — New notice

Reported sold: $1,500,000 · Target: $1,500,000

Rule 506(b)·9 investors

Fundraising Profile

Exemptions

Rule 506(b)

Investors in latest filing

Revenue Range

Decline to Disclose

Reported commissions across identified offerings

Amendment Rate

33%

Latest reported sold across 2 identified offerings

$42,498,390

Uses the latest linked filing for each offering. This is not a measure of money raised in the last year or verified lifetime funding.

Key People

David Anderson

Related Person

Appears on 2 filings

Christian Cobaugh

Related Person

Appears on 2 filings

Christian Cobaugh

Related Person

Appears on 1 filing

Gustavo Mahler

Related Person

Appears on 1 filing

Daniella Kranjac

Related Person

Appears on 1 filing

Errik Anderson

Related Person

Appears on 1 filing

Errik Anderson

Related Person

Appears on 1 filing

Filing History

Date	Type	Offering target	Reported sold	Investors
Jun 16, 2023	Amendment	$40,998,390	$40,998,390	10
May 25, 2022	New	$20,998,407	$20,998,407	10
May 24, 2021	New	$1,500,000	$1,500,000	9

Filing History

Amendment insights

Loading amendment history…

Comparable issuers

Matched on reported industry and issuer type, then ranked by business location, offering target, and recency. These are filing comparables, not verified business competitors.

Traws Pharma, Inc.

Biotechnology

Offering target: $50,000,000

Filed Nov 5, 2026